Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
1998-03-26
2010-06-01
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S488000, C424S485000, C424S465000, C424S479000, C424S441000, C424S481000, C514S772400, C514S974000
Reexamination Certificate
active
07727552
ABSTRACT:
A composition of an oral medicine or an oral medicine which can prevent an unpleasant taste of the medicine is herein disclosed. It is granules, powders, syrups and the like which is prevented from an unpleasant taste, comprising a basic medicine having an unpleasant taste and an anionic polymer such as carrageenan.
REFERENCES:
patent: 4313529 (1982-02-01), Kato et al.
patent: 4725440 (1988-02-01), Ridgway et al.
patent: 5013557 (1991-05-01), Tai
patent: 5077053 (1991-12-01), Kuncewitch et al.
patent: 5084278 (1992-01-01), Mehta
patent: 5286489 (1994-02-01), Tsau et al.
patent: 5288501 (1994-02-01), Nurnberg et al.
patent: 5464612 (1995-11-01), Matoba et al.
patent: 5466464 (1995-11-01), Masaki et al.
patent: 5489436 (1996-02-01), Hoy et al.
patent: 5576014 (1996-11-01), Mizumoto et al.
patent: 5612026 (1997-03-01), Diehl
patent: 5656284 (1997-08-01), Balkin et al.
patent: 5763449 (1998-06-01), Anaebonam et al.
patent: 5827507 (1998-10-01), Oshima et al.
patent: 5874074 (1999-02-01), Smith
patent: 5955106 (1999-09-01), Moeckel et al.
patent: 5962535 (1999-10-01), Miyamoto et al.
patent: 6214386 (2001-04-01), Santus et al.
patent: 6368625 (2002-04-01), Siebert et al.
patent: 6455053 (2002-09-01), Okada et al.
patent: 6576677 (2003-06-01), Ukai et al.
patent: 6586004 (2003-07-01), Shimizu et al.
patent: 6656492 (2003-12-01), Kajiyama et al.
patent: 6743443 (2004-06-01), Furitsu et al.
patent: 0 590 963 (1994-04-01), None
patent: 0 691 122 (1996-01-01), None
patent: 0 748 628 (1996-12-01), None
patent: 0 753 296 (1997-01-01), None
patent: 0 922 464 (1999-06-01), None
patent: 1 120 120 (2000-08-01), None
patent: 51-76413 (1976-07-01), None
patent: 5476818 (1979-06-01), None
patent: 60-204712 (1985-10-01), None
patent: 61-130239 (1986-06-01), None
patent: 03-005418 (1991-01-01), None
patent: 4282312 (1991-10-01), None
patent: 03-287535 (1991-12-01), None
patent: 04-018015 (1992-01-01), None
patent: 4-235136 (1992-08-01), None
patent: 4-235136 (1992-08-01), None
patent: 4-262758 (1992-08-01), None
patent: 4-346937 (1992-12-01), None
patent: 4346937 (1992-12-01), None
patent: 5-163154 (1993-08-01), None
patent: 5-271054 (1993-10-01), None
patent: 6-218028 (1994-08-01), None
patent: 07267850 (1995-10-01), None
patent: 8-19589 (1996-01-01), None
patent: 8-333245 (1996-12-01), None
patent: 9-48726 (1997-02-01), None
patent: 09-143100 (1997-06-01), None
patent: 10-0036292 (1998-02-01), None
patent: 10-114683 (1998-05-01), None
patent: 2807346 (1998-07-01), None
patent: 41-1106353 (1999-04-01), None
patent: 11-199517 (1999-07-01), None
patent: 11-228450 (1999-08-01), None
patent: 2005-041887 (2005-02-01), None
patent: WO 99/18936 (1999-04-01), None
patent: WO-00/20033 (2000-04-01), None
patent: WO-00/25754 (2000-05-01), None
Drug Information on Vantin® by Pharmacia /& upjohn, obtained through on-line PDR (revised Nov. 2000).
Research Disclosure 176019 (Derwent WPI Acc No. 78-92367 A/51) (1978).
Drug Information for Vantin, Physicain's Desk Reference- 1995.
Kawakami, Y.; Inoue, A.; Kawai, T.; Wakita, M.; Sugimoto, H. Hopfinger, A. J. Bioorganic & Med, Chem. Lett. 1996, 4, (1429-1446).
1998 Physician Desk Reference, p. 1203.
Wade and Weller-Editors: Handbook of Pharmaceutical Excipients, Povidone, p. 392, 1994.
Supplementary Search Report issued on Jan. 27, 2006, in connection with European Patent Application No. 01 908 204.9-2123.
Official European Patent Office Communication dated Sep. 13, 2006, issued in connection with European Patent Application No. 01 908 402.9-2123.
Applicant's Response dated Mar. 19, 2007, in response to Official Communication issued on Sep. 13, 2006, in connection with European Patent Application No. 01 908 204.9-2123.
Official European Patent Office Communication dated Oct. 17, 2008, issued in connection with European Patent Application No. 01 908 204.9-2123.
Applicant's Response dated Jan. 23, 2009, in response to Official Communication issued on Oct. 17, 2008, in connection with European Patent Application No. 01 908 204.9-2123.
Notice of Acceptance issued Feb. 20, 2009, in connection with European Patent Application No. 01 908 204.9-2123.
U.S. Appl. No. 10/203,687 dated Oct. 20, 2004.
U.S. Appl. No. 10/203,687 dated Jul. 13, 2005.
U.S. Appl. No. 10/203,687 dated Mar. 06, 2006.
U.S. Appl. No. 10/203,687 dated Jan. 16, 2007.
U.S. Appl. No. 10/203,687 dated Nov. 30, 2007.
U.S. Appl. No. 10/203,687 dated Aug. 15, 2008.
Hrada Tsutomu
Suzuki Yasuyuki
Ukai Koji
Birch & Stewart Kolasch & Birch, LLP
Eisai R&D Management Co., Ltd.
Haghighatian Mina
LandOfFree
Oral pharmaceutical preparations decreased in bitterness by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral pharmaceutical preparations decreased in bitterness by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral pharmaceutical preparations decreased in bitterness by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4220553